Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome (Q80831463)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324421%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324421%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

Viktória Sümegi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324421%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Ibolya Haszon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324421%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Csaba Bereczki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324421%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Ferenc Papp

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324421%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sándor Túri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324421%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

7 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324421%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324421%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324421%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324421%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

1085-1092

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324421%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00467-008-0771-8

3 January 2020

exact match

0 references

cites work

Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie

1 reference

12 December 2020

Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose

1 reference

12 December 2020

Cyclosporin and the Glomerular Filtration Barrier in Minimal Change Disease and Membranous Glomerulopathy

1 reference

12 December 2020

Recovery from cyclosporine-associated arteriolopathy in childhood nephrotic syndrome

1 reference

12 December 2020

Consensus statement on management and audit potential for steroid responsive nephrotic syndrome. Report of a Workshop by the British Association for Paediatric Nephrology and Research Unit, Royal College of Physicians

1 reference

12 December 2020

Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology

1 reference

12 December 2020

Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children

1 reference

12 December 2020

Nephrotic syndrome in childhood.

1 reference

12 December 2020

Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome

1 reference

12 December 2020

National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification

1 reference

12 December 2020

Intravenous cyclophosphamide is the drug of choice for steroid dependent nephrotic syndrome

1 reference

12 December 2020

Management of the nephrotic syndrome in children

1 reference

12 December 2020

Cytotoxic drugs in steroid-resistant renal disease. Alkylating and antimetabolic agents in the treatment of nephrotic syndrome, lupus nephritis, chronic glomerulonephritis, and purpura nephritis in children

1 reference

12 December 2020

Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis

1 reference

12 December 2020

Therapy of focal and segmental glomerulosclerosis with methylprednisolone, cyclosporine A, and prednisone

1 reference

12 December 2020

Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal

1 reference

12 December 2020

Steroid-resistant nephrotic syndrome: long-term evolution after sequential therapy

1 reference

12 December 2020

Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome

1 reference

12 December 2020

Cyclophosphamide Therapy in the Nephrotic Syndrome in Childhood

1 reference

12 December 2020

Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children

1 reference

12 December 2020

Long-term effects of levamisole treatment in childhood nephrotic syndrome

1 reference

12 December 2020

Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings

1 reference

12 December 2020

Long term follow up of steroid and cyclophosphamide therapy in nephrosis

1 reference

12 December 2020

A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.

1 reference

12 December 2020

Cyclophosphamide therapy of idiopathic nephrosis

1 reference

12 December 2020

Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome

1 reference

12 December 2020

Long-term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood

1 reference

12 December 2020

Stability of remission in minimal lesion nephrotic syndrome after treatment with prednisolone and cyclophosphamide.

1 reference

12 December 2020

Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood

1 reference

12 December 2020

Secondary resistance to cyclosporin A in children with nephrotic syndrome

1 reference

12 December 2020

Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence

1 reference

12 December 2020

Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.

1 reference

12 December 2020

The use of steroid-sparing agents in steroid-sensitive nephrotic syndrome

1 reference

12 December 2020

The significance of focal global sclerosis in idiopathic nephrotic syndrome. Long-term clinical observations

1 reference

12 December 2020

Biological effects of cyclosporin A: a new antilymphocytic agent. 1976.

1 reference

12 December 2020

Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie

1 reference

12 December 2020

A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children

1 reference

12 December 2020